RECRUITINGOBSERVATIONAL
Korean Heart Failure Registry III
Korean Heart Failure Registry Ⅲ of Korean Society of Heart Failure
About This Trial
KorHF III is a multi-center, nationwide, prospective registry of the Korean Society of Heart Failure, which enrolls patients with acute heart failure in Korea. The aim of this registry is to analyze the etiology, treatment, treatment, and prognosis to develop strategies for managing acute heart failure.
Who May Be Eligible (Plain English)
All consecutive hospitalized adult heart failure patients who fulfill one of 1-3 and 4
Who May Qualify:
1. Symptoms of heart failure
2. Signs of heart failure
3. Lung congestion in Chest-x-ray
4. Objective finding of structural and/or functional disorder of the heart or elevated natriuretic peptide levels
Who Should NOT Join This Trial:
1. Patients younger than 18 years old
2. Patients who do no consent
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
All consecutive hospitalized adult heart failure patients who fulfill one of 1-3 and 4
Inclusion Criteria:
1. Symptoms of heart failure
2. Signs of heart failure
3. Lung congestion in Chest-x-ray
4. Objective finding of structural and/or functional disorder of the heart or elevated natriuretic peptide levels
Exclusion Criteria:
1. Patients younger than 18 years old
2. Patients who do no consent
Locations (1)
Seoul National University Bundang Hospital
Seongnam, South Korea